纤维化型过敏性肺炎的肺微环境与疾病进展
研究对9例纤维化型过敏性肺炎(fHP) explant 肺和6例未使用供体肺对照进行系统采样,每肺4份,按微CT分为轻、中、重纤维化组,用加权基因共表达网络等分析基因表达。发现6种分子特征与肺受累差异相关,并与独立临床fHP队列的体内疾病行为相关;所有特征也见于IPF,转录组格局更多由局部疾病范围而非诊断决定。
要点
- fHP中细胞外基质和抗原呈递/致敏特征见于仅轻度结构改变的肺区。
- 蜂窝样变和B细胞特征主导最严重受累肺区的转录组。
- 随疾病严重度增加,内皮功能逐步丧失并出现细胞稳态紊乱。
核心结论
- 识别出6种分子特征可刻画fHP形态学进展并与体内临床行为相关。
- 比较IPF与fHP,转录组格局更多由局部疾病范围而非诊断决定。
研究设计与样本
- 9例fHP explant 肺和6例未使用供体肺作对照,每肺系统采样4份。
- 按微CT将fHP核心分为轻度、中度、重度纤维化组。
- 用加权基因共表达网络分析、xCell、基因本体和结构富集分析评估基因表达谱。
- 将主要分子特征的基因表达与特发性肺纤维化(IPF)比较。
- 在独立临床fHP队列中用组织、BAL样本和CT扫描评估explant肺发现。
主要发现
- 发现6种分子特征与不同肺受累相关。
- fHP中细胞外基质和抗原呈递/致敏转录组特征见于仅有轻度结构和组织学改变的肺区。
- 蜂窝样变和B细胞特征主导最严重受累肺区的转录组。
- 随疾病严重度增加,内皮功能逐步丧失并出现正常细胞稳态过程的进行性破坏。
- 6种特征也见于IPF且与疾病微环境关联大致相似。
临床怎么用
- fHP进展评估可关注6种分子特征对应的肺区微环境变化。
- 轻度结构改变肺区已见细胞外基质和抗原呈递/致敏特征,提示早期分子干预窗口。
- 严重受累肺区以蜂窝样变和B细胞特征为主,提示进展期不同机制。
- IPF与fHP共享分子特征,临床可依据局部疾病范围而非仅诊断解读转录组信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Fibrotic hypersensitivity pneumonitis (fHP) is an interstitial lung disease caused by sensitization to an inhaled allergen. Objectives: To identify the molecular determinants associated with progression of fibrosis. Methods: Nine fHP explant lungs and six unused donor lungs (as controls) were systematically sampled (4 samples/lung). According to microcomputed tomography measures, fHP cores were clustered into mild, moderate, and severe fibrosis groups. Gene expression profiles were assessed using weighted gene co-expression network analysis, xCell, gene ontology, and structure enrichment analysis. Gene expression of the prevailing molecular traits was also compared with idiopathic pulmonary fibrosis (IPF). The explant lung findings were evaluated in separate clinical fHP cohorts using tissue, BAL samples, and computed tomography scans. Measurements and Main Results: We found six molecular traits that associated with differential lung involvement. In fHP, extracellular matrix and antigen presentation/sensitization transcriptomic signatures characterized lung zones with only mild structural and histological changes, whereas signatures involved in honeycombing and B cells dominated the transcriptome in the most severely affected lung zones. With increasing disease severity, endothelial function was progressively lost, and progressive disruption in normal cellular homeostatic processes emerged. All six were also found in IPF, with largely similar associations with disease microenvironments. The molecular traits correlated with in vivo disease behavior in a separate clinical fHP cohort. Conclusions: We identified six molecular traits that characterize the morphological progression of fHP and associate with in vivo clinical behavior. Comparing IPF with fHP, the transcriptome landscape was determined considerably by local disease extent rather than by diagnosis alone.
引用
- De Sadeleer LJ, McDonough JE, Schupp JC, et al. Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2022. PMID: 34724391. doi:10.1164/rccm.202103-0569OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。